DOMESTIC AND FOREIGN EXPERIENCE ANALYSIS OF PLANNING AND REGULATORY RESEARCH IN PHARMACEUTICALS

Aim. To conduct an analysis of the management of innovation activities for innovative medicines market launch in Russia and abroad.

Material and Methods. The methods of cognition (including methods of empirical (observation, comparison) and theoretical research (analysis, synthesis, aggregation)), expert assessments, SWOT analysis were used in the research.

Results. The analysis of domestic and foreign experience in planning and regulating research in the field of pharmaceutics is carried out. Despite the fact that at present a powerful ramified state apparatus for regulating scientific research and development in the field of medicine has been formed in the Russian Federation, the pharmaceutical science remains divided. This leads to a decrease in the effectiveness of research in the field of pharmaceuticals. At the same time, in developed countries, interdepartmental coordination and advisory bodies (councils, commissions) are active, often at the highest level. This testifies to the high attention given in these countries to interdepartmental interaction and intersectoral projects in the field of research and development.

Conclusion. Foreign R & D support systems are characterized by a number of differences from domestic mechanisms. A number of recommendations based on the experience of foreign colleagues for future measures to modernize existing and introduce new mechanisms for state support of research in the field of pharmaceuticals in Russia are proposed.